Abstract
The melanoma differentiation-associated gene-7 (mda-7) was identified by virtue of its enhanced expression in human melanoma cells induced into terminal differentiation. Enforced expression of mda-7 in human cancer cell lines of diverse origins results in the suppression of growth and induction of apoptosis. We have shown that adenoviral-mediated mda-7 (Ad-mda7) radiosensitizes non-small-cell lung cancer (NSCLC) cells by enhancing the apoptotic pathway. To identify the mechanism of this radiosensitization, we examined the level of proteins involved in the nonhomologous end-joining (NHEJ) pathway of DNA double-strand break (DSB) repair. Western blot analysis indicated that the expression of NHEJ pathway components Ku70, XRCC4, and DNA ligase IV was downregulated in NSCLC cells – A549 with Ad-mda7 treatment. No such change was observed in normal human CCD16 fibroblasts previously shown not to be radiosensitized by Ad-mda7. The biological significance of these changes of expression of proteins critical for repair of radiation-induced DSBs was confirmed via the analysis of DSB rejoining kinetics using pulsed field gel electrophoresis and assessment of host cell reactivation capacity following Ad-mda7 treatment. Based on these results, we hypothesize that Ad-mda7 sensitizes NSCLC cells to ionizing radiation by suppressing the activity of NHEJ, a pathway essential for repair of radiation-induced DSBs.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Allalunis-Turner MJ, Barron GM, Day III RS, Dobler KD and Mirzayans R . (1993). Radiat. Res., 134, 349–354.
Blumberg H, Conklin D, Xu WF, Grossmann A, Brender T, Carollo S, Eagan M, Foster D, Haldeman BA, Hammond A, Haugen H, Jelinek L, Kelly JD, Madden K, Maurer MF, Parrish-Novak J, Prunkard D, Sexson S, Sprecher C, Waggie K, West J, Whitmore TE, Yao L, Kuechle MK, Dale BA and Chandrasekher YA . (2001). Cell, 104, 9–19.
Bryans M, Valenzano MC and Stamato TD . (1999). Mutat. Res., 433, 53–58.
Collis SJ, Swartz MJ, Nelson WG and DeWeese TL . (2003). Cancer Res., 63, 1550–1554.
Critchlow SE and Jackson SP . (1998). Trends Biochem. Sci., 23, 394–398.
Eady JJ, Peacock JH and McMillan TJ . (1992). Br. J. Cancer, 66, 113–118.
Grawunder U, Wilm M, Wu X, Kulesza P, Wilson TE, Mann M and Lieber MR . (1997). Nature, 388, 492–495.
Gu Y, Jin S, Gao Y, Weaver DT and Alt FW . (1997a). Proc. Natl. Acad. Sci. USA, 94, 8076–8081.
Haber JE . (2000). Trends Genet., 16, 259–264.
Hopfner KP, Putnam CD and Tainer JA . (2002). Curr. Opin. Struct. Biol., 12, 115–122.
Huang EY, Madireddi MT, Gopalkrishnan RV, Leszczyniecka M, Su Z, Lebedeva IV, Kang D, Jiang H, Lin JJ, Alexandre D, Chen Y, Vozhilla N, Mei MX, Christiansen KA, Sivo F, Goldstein NI, Mhashilkar AB, Chada S, Huberman E, Pestka S and Fisher PB . (2001). Oncogene, 20, 7051–7063.
Jeggo PA . (1998). Radiat. Res., 150, S80–91.
Jiang H, Lin JJ, Su ZZ, Goldstein NI and Fisher PB . (1995). Oncogene, 11, 2477–2486.
Jiang H, Su ZZ, Lin JJ, Goldstein NI, Young CS and Fisher PB . (1996). Proc. Natl. Acad. Sci. USA, 93, 9160–9165.
Junop MS, Modesti M, Guarne A, Ghirlando R, Gellert M and Yang W . (2000). EMBO J., 19, 5962–5970.
Kawabe S, Nishikawa T, Munshi A, Roth JA, Chada S and Meyn RE . (2002). Mol. Ther., 6, 637–644.
Khanna KK and Jackson SP . (2001). Nat. Genet., 27, 247–254.
Kurimasa A, Kumano S, Boubnov NV, Story MD, Tung CS, Peterson SR and Chen DJ . (1999). Mol. Cell. Biol., 19, 3877–3884.
Lees-Miller SP, Godbout R, Chan DW, Weinfeld M, Day III RS, Barron GM and Allalunis-Turner J . (1995). Science, 267, 1183–1185.
Li GC, He F, Shao X, Urano M, Shen L, Kim D, Borrelli M, Leibel SA, Gutin PH and Ling CC . (2003). Cancer Res., 63, 3268–3274.
Lieber MR . (1999). Genes Cells, 4, 77–85.
McDonald III ER, Wu GS, Waldman T and El-Deiry WS . (1996). Cancer Res., 56, 2250–2255.
Mhashilkar AM, Schrock RD, Hindi M, Liao J, Sieger K, Kourouma F, Zou-Yang XH, Onishi E, Takh O, Vedvick TS, Fanger G, Stewart L, Watson GJ, Snary D, Fisher PB, Saeki T, Roth JA, Ramesh R and Chada S . (2001). Mol. Med., 7, 271–282.
Olive PL . (1998). Radiat. Res., 150, S42–51.
Omori S, Takiguchi Y, Suda A, Sugimoto T, Miyazawa H, Tanabe N, Tatsumi K, Kimura H, Pardington PE, Chen F, Chen DJ and Kuriyama T . (2002). DNA Repair (Amst.), 1, 299–310.
Parker SL, Tong T, Bolden S and Wingo PA . (1997). CA Cancer J. Clin., 47, 5–27.
Pataer A, Vorburger SA, Barber GN, Chada S, Mhashilkar AM, Zou-Yang H, Stewart AL, Balachandran S, Roth JA, Hunt KK and Swisher SG . (2002). Cancer Res., 62, 2239–2243.
Peng Y, Zhang Q, Nagasawa H, Okayasu R, Liber HL and Bedford JS . (2002). Cancer Res., 62, 6400–6404.
Rainbow AJ . (1974). Radiat. Res., 60, 155–164.
Rainbow AJ and Mak S . (1972). Radiat. Res., 50, 319–333.
Riballo E, Critchlow SE, Teo SH, Doherty AJ, Priestley A, Broughton B, Kysela B, Beamish H, Plowman N, Arlett CF, Lehmann AR, Jackson SP and Jeggo PA . (1999). Curr. Biol., 9, 699–702.
Sado K, Ayusawa D, Enomoto A, Suganuma T, Oshimura M, Sato K and Koyama H . (2001). J. Biol. Chem., 276, 9742–9748.
Saeki T, Mhashilkar A, Chada S, Branch C, Roth JA and Ramesh R . (2000). Gene Therapy, 7, 2051–2057.
Saeki T, Mhashilkar A, Swanson X, Zou-Yang XH, Sieger K, Kawabe S, Branch CD, Zumstein L, Meyn RE, Roth JA, Chada S and Ramesh R . (2002). Oncogene, 21, 4558–4566.
Sarkar D, Su ZZ, Lebedeva IV, Sauane M, Gopalkrishnan RV, Valerie K, Dent P and Fisher PB . (2002). Proc. Natl. Acad. Sci. USA, 99, 10054–10059.
Sibanda BL, Critchlow SE, Begun J, Pei XY, Jackson SP, Blundell TL and Pellegrini L . (2001). Nat. Struct. Biol., 8, 1015–1019.
Smith GC and Jackson SP . (1999). Genes Dev., 13, 916–934.
Story MD, Mendoza EA, Meyn RE and Tofilon PJ . (1994). Int. J. Radiat. Biol., 65, 523–528.
Su ZZ, Lebedeva IV, Sarkar D, Gopalkrishnan RV, Sauane M, Sigmon C, Yacoub A, Valerie K, Dent P and Fisher PB . (2003). Oncogene, 22, 1164–1180.
Walker JR, Corpina RA and Goldberg J . (2001). Nature, 412, 607–614.
Acknowledgements
This study was supported in part by Grants R41 CA88421, P01 CA78778, P01 CA06294, and P30 CA16672 from the National Cancer Institute and a sponsored research agreement with Introgen Therapeutics, Inc. The vectors used in this research were the kind gift of Introgen Therapeutics, Inc.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nishikawa, T., Munshi, A., Story, M. et al. Adenoviral-mediated mda-7 expression suppresses DNA repair capacity and radiosensitizes non-small-cell lung cancer cells. Oncogene 23, 7125–7131 (2004). https://doi.org/10.1038/sj.onc.1207917
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1207917
Keywords
This article is cited by
-
mda-7 gene transfer sensitizes breast carcinoma cells to chemotherapy, biologic therapies and radiotherapy: correlation with expression of bcl-2 family members
Cancer Gene Therapy (2006)
-
Combinatorial synergy induced by adenoviral-mediated mda-7 and Herceptin in Her-2+ breast cancer cells
Cancer Gene Therapy (2006)